Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000595314 | SCV000703382 | uncertain significance | not provided | 2016-11-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000595314 | SCV001788620 | likely benign | not provided | 2020-03-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002062022 | SCV002388752 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2F | 2024-07-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341519 | SCV002641116 | likely benign | Inborn genetic diseases | 2022-04-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000595314 | SCV005890612 | likely benign | not provided | 2024-12-01 | criteria provided, single submitter | clinical testing | SGCD: BP4, BP7 |